Ketoconazole-induced Sweet syndrome: a new association

Am J Dermatopathol. 2015 May;37(5):419-22. doi: 10.1097/DAD.0000000000000252.

Abstract

Sweet syndrome (SS) is an acute febrile neutrophilic dermatosis that can be associated with malignancy and medications. A 60-year-old man presented with erythematous, edematous, and ulcerated plaques in the extensor surface of the upper extremities, after a ketoconazole course due to pityrosporum folliculitis. Skin biopsy showed a dense dermal neutrophilic infiltrate, associated with marked papillary dermal edema. Blood count showed leukocytosis and neutrophilia. Skin lesions resolved spontaneously with discoloration after 2 weeks of discontinuation of ketoconazole. Although most cases of drug-induced SS are associated with granulocyte colony-stimulating factor, other medications need to be considered. This is the first reported case of ketoconazole-induced SS despite its widespread use.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / adverse effects*
  • Biopsy
  • Drug Eruptions / etiology*
  • Drug Eruptions / immunology
  • Drug Eruptions / pathology
  • Humans
  • Ketoconazole / adverse effects*
  • Male
  • Middle Aged
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Sweet Syndrome / chemically induced*
  • Sweet Syndrome / immunology
  • Sweet Syndrome / pathology

Substances

  • Antifungal Agents
  • Ketoconazole